PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, United Kingdom.\', \'Open Targets, Wellcome Genome Campus, Hinxton, United Kingdom.\', \'European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus, Cambridge, United Kingdom.\', \'Bristol-Myers Squibb, Cambridge, United States.\', \'Medical Research Council (MRC) Integrative Epidemiology Unit, Department of Population Health Sciences, University of Bristol, Bristol, United Kingdom.\', \'Clinical Trial Service Unit and Epidemiological Studies Unit (CTSU), Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom.\', \'Medical Research Council Population Health Research Unit (MRC PHRU), Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom.\', \'Icelandic Heart Association, Kopavogur, Iceland.\', \'Faculty of Medicine, University of Iceland, Reykjavik, Iceland.\', \'Department of Biology, York Biomedical Research Institute, Hull York Medical School, University of York, York, United Kingdom.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.7554/eLife.69719e69719
?:doi
?:hasPublicationType
?:journal
  • eLife
is ?:pmid of
?:pmid
?:pmid
  • 34402426
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 7.121
?:rankingScore_hIndex
  • 74
?:title
  • A proteome-wide genetic investigation identifies several SARS-CoV-2-exploited host targets of clinical relevance.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all